# Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy

> **NCT07052799** · PHASE3 · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 2514 (estimated)

## Conditions studied

- Myocardial Infarction (MI)
- Cardiovascular Events
- Post Polypectomy Bleeding in Antiplatelet Patients

## Interventions

- **DRUG:** Aspirin 80mg
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT07052799
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-10
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 2514 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07052799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07052799, "Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT07052799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*